首页> 美国卫生研究院文献>Journal of Medical Genetics >Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment
【2h】

Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment

机译:hMLH1和hMSH2基因突变的携带者患大肠癌和子宫内膜癌的风险:确定的校正

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Hereditary non-polyposis colorectal cancer (HNPCC) is caused by germline mutations of mismatch repair genes, usually in hMLH1 or hMSH2. All earlier studies on penetrance except one population based study were conducted in HNPCC families and did not correct for the way in which these families were ascertained. >Objective: To obtain estimates of the risk of colorectal cancer (CRC) and endometrial cancer (EC) for carriers of disease causing mutations of the hMSH2 and hMLH1 genes. >Methods: Families with known germline mutations of hMLH1 (n = 39) and hMSH2 (n = 45) were extracted from the Dutch HNPCC cancer registry. Ascertainment-corrected maximum likelihood estimation was carried out on a competing risks model for cancer of the colorectum and endometrium. >Results: Both loci were analysed jointly as there was no significant difference in risk (p = 0.08). At age 70, colorectal cancer risk for men was 26.7% (95% confidence interval, 12.6% to 51.0%) and for women, 22.4% (10.6% to 43.8%); the risk for endometrial cancer was 31.5% (11.1% to 70.3%). >Conclusions: Current estimates of the CRC risk of mutations to the hMLH1 and hMSH2 locus should be replaced by considerably lower risks which account for the selection of the families.
机译:>背景:遗传性非息肉性结直肠癌(HNPCC)是由错配修复基因的种系突变引起的,通常在hMLH1或hMSH2中。除一项基于人群的研究外,所有较早的外显率研究均在HNPCC家庭中进行,并没有纠正确定这些家庭的方式。 >目的:获得导致hMSH2和hMLH1基因突变的疾病携带者对结直肠癌(CRC)和子宫内膜癌(EC)的风险估计。 >方法:从荷兰HNPCC癌症登记处提取出具有已知hMLH1(n = 39)和hMSH2(n = 45)种系突变的家庭。对结肠直肠癌和子宫内膜癌的竞争风险模型进行了确定校正的最大似然估计。 >结果:由于风险没有显着差异(p = 0.08),因此共同分析了两个基因座。在70岁时,男性的大肠癌风险为26.7%(95%置信区间为12.6%至51.0%),女性为22.4%(10.6%至43.8%)。子宫内膜癌的风险为31.5%(11.1%至70.3%)。 >结论:应将当前对hMLH1和hMSH2基因座突变的CRC风险估计值替换为相当低的风险,这些风险可用于选择家庭。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号